151 related articles for article (PubMed ID: 38430390)
1. Combination of IL-33 with PD-1 blockade augment mILC2s-mediated anti-tumor immunity.
Yue J; Guo H; Xu P; Ma J; Shi W; Wu Y
Cancer Immunol Immunother; 2024 Mar; 73(4):65. PubMed ID: 38430390
[TBL] [Abstract][Full Text] [Related]
2. ILC2s amplify PD-1 blockade by activating tissue-specific cancer immunity.
Moral JA; Leung J; Rojas LA; Ruan J; Zhao J; Sethna Z; Ramnarain A; Gasmi B; Gururajan M; Redmond D; Askan G; Bhanot U; Elyada E; Park Y; Tuveson DA; Gönen M; Leach SD; Wolchok JD; DeMatteo RP; Merghoub T; Balachandran VP
Nature; 2020 Mar; 579(7797):130-135. PubMed ID: 32076273
[TBL] [Abstract][Full Text] [Related]
3. A novel type-2 innate lymphoid cell-based immunotherapy for cancer.
Saranchova I; Xia CW; Besoiu S; Finkel PL; Ellis SLS; Kari S; Munro L; Pfeifer CG; Fazli L; Gleave ME; Jefferies WA
Front Immunol; 2024; 15():1317522. PubMed ID: 38524132
[TBL] [Abstract][Full Text] [Related]
4. Anti-ST2 Nanoparticle Alleviates Lung Inflammation by Targeting ILC2s-CD4
Wu Y; Shi W; Wang H; Yue J; Mao Y; Zhou W; Kong X; Guo Q; Zhang L; Xu P; Wang Y
Int J Nanomedicine; 2020; 15():9745-9758. PubMed ID: 33299314
[TBL] [Abstract][Full Text] [Related]
5. Group 2 innate lymphoid cells contribute to IL-33-mediated alleviation of cardiac fibrosis.
Chen WY; Wu YH; Tsai TH; Li RF; Lai AC; Li LC; Yang JL; Chang YJ
Theranostics; 2021; 11(6):2594-2611. PubMed ID: 33456562
[No Abstract] [Full Text] [Related]
6. PD-1 Affects the Immunosuppressive Function of Group 2 Innate Lymphoid Cells in Human Non-Small Cell Lung Cancer.
Shen C; Liu C; Zhang Z; Ping Y; Shao J; Tian Y; Yu W; Qin G; Liu S; Wang L; Zhang Y
Front Immunol; 2021; 12():680055. PubMed ID: 34194433
[TBL] [Abstract][Full Text] [Related]
7. Interplay Between the IL-33/ST2 Axis and Bone Marrow ILC2s in Protease Allergen-Induced IL-5-Dependent Eosinophilia.
Boberg E; Johansson K; Malmhäll C; Calvén J; Weidner J; Rådinger M
Front Immunol; 2020; 11():1058. PubMed ID: 32582171
[No Abstract] [Full Text] [Related]
8. Respiratory syncytial virus prevents the subsequent development of ovalbumin-induced allergic responses by inhibiting ILC2 via the IL-33/ST2 pathway.
Wang D; Bai S; Cui Y; Zhao N; Qi F; Liu J; Zeng S; Xu L; Hu H; Liu B
Immunotherapy; 2018 Sep; 10(12):1065-1076. PubMed ID: 30027786
[TBL] [Abstract][Full Text] [Related]
9. IL-17-producing ST2
Cai T; Qiu J; Ji Y; Li W; Ding Z; Suo C; Chang J; Wang J; He R; Qian Y; Guo X; Zhou L; Sheng H; Shen L; Qiu J
J Allergy Clin Immunol; 2019 Jan; 143(1):229-244.e9. PubMed ID: 29625134
[TBL] [Abstract][Full Text] [Related]
10. Sepsis Induces Deregulation of IL-13 Production and PD-1 Expression in Lung Group 2 Innate Lymphoid Cells.
Akama Y; Park EJ; Satoh-Takayama N; Gaowa A; Ito A; Kawamoto E; Darkwah S; Appiah MG; Myint PK; Ohno H; Imai H; Shimaoka M
Shock; 2021 Mar; 55(3):357-370. PubMed ID: 32826811
[TBL] [Abstract][Full Text] [Related]
11. PD-1 Blockade on Tumor Microenvironment-Resident ILC2s Promotes TNF-α Production and Restricts Progression of Metastatic Melanoma.
Howard E; Hurrell BP; Helou DG; Quach C; Painter JD; Shafiei-Jahani P; Fung M; Gill PS; Soroosh P; Sharpe AH; Akbari O
Front Immunol; 2021; 12():733136. PubMed ID: 34531874
[TBL] [Abstract][Full Text] [Related]
12. Interferon-γ constrains cytokine production of group 2 innate lymphoid cells.
Kudo F; Ikutani M; Seki Y; Otsubo T; Kawamura YI; Dohi T; Oshima K; Hattori M; Nakae S; Takatsu K; Takaki S
Immunology; 2016 Jan; 147(1):21-9. PubMed ID: 26425820
[TBL] [Abstract][Full Text] [Related]
13. Systemic administration of IL-33 induces a population of circulating KLRG1
Guillerey C; Stannard K; Chen J; Krumeich S; Miles K; Nakamura K; Smith J; Yu Y; Ng S; Harjunpää H; Teng MW; Engwerda C; Belz GT; Smyth MJ
Immunol Cell Biol; 2021 Jan; 99(1):65-83. PubMed ID: 32748462
[TBL] [Abstract][Full Text] [Related]
14. PPARɣ drives IL-33-dependent ILC2 pro-tumoral functions.
Ercolano G; Gomez-Cadena A; Dumauthioz N; Vanoni G; Kreutzfeldt M; Wyss T; Michalik L; Loyon R; Ianaro A; Ho PC; Borg C; Kopf M; Merkler D; Krebs P; Romero P; Trabanelli S; Jandus C
Nat Commun; 2021 May; 12(1):2538. PubMed ID: 33953160
[TBL] [Abstract][Full Text] [Related]
15. T-bet inhibits innate lymphoid cell-mediated eosinophilic airway inflammation by suppressing IL-9 production.
Matsuki A; Takatori H; Makita S; Yokota M; Tamachi T; Suto A; Suzuki K; Hirose K; Nakajima H
J Allergy Clin Immunol; 2017 Apr; 139(4):1355-1367.e6. PubMed ID: 27670243
[TBL] [Abstract][Full Text] [Related]
16. Sex differences exist in adult heart group 2 innate lymphoid cells.
Peng H; Wu S; Wang S; Yang Q; Wang L; Zhang S; Huang M; Li Y; Xiong P; Zhang Z; Cai Y; Li L; Deng Y; Deng Y
BMC Immunol; 2022 Oct; 23(1):52. PubMed ID: 36316644
[TBL] [Abstract][Full Text] [Related]
17. Group 2 innate lymphoid cells promote TNBC lung metastasis via the IL-13-MDSC axis in a murine tumor model.
Zhao N; Zhu W; Wang J; Liu W; Kang L; Yu R; Liu B
Int Immunopharmacol; 2021 Oct; 99():107924. PubMed ID: 34217145
[TBL] [Abstract][Full Text] [Related]
18. Lung group 2 innate lymphoid cells differentially depend on local IL-7 for their distribution, activation, and maintenance in innate and adaptive immunity-mediated airway inflammation.
Takami D; Abe S; Shimba A; Asahi T; Cui G; Tani-Ichi S; Hara T; Miyata K; Ikutani M; Takatsu K; Oike Y; Ikuta K
Int Immunol; 2023 Nov; 35(11):513-530. PubMed ID: 37493250
[TBL] [Abstract][Full Text] [Related]
19. The NF-κB Transcription Factor c-Rel Modulates Group 2 Innate Lymphoid Cell Effector Functions and Drives Allergic Airway Inflammation.
Mindt BC; Krisna SS; Duerr CU; Mancini M; Richer L; Vidal SM; Gerondakis S; Langlais D; Fritz JH
Front Immunol; 2021; 12():664218. PubMed ID: 34867937
[TBL] [Abstract][Full Text] [Related]
20. Neuronal-Activated ILC2s Promote IL-17A Production in Lung γδ T Cells During Sepsis.
Chen W; Lai D; Li Y; Wang X; Pan Y; Fang X; Fan J; Shu Q
Front Immunol; 2021; 12():670676. PubMed ID: 33995408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
